Therapeutic Apheresis and Long COVID
This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte stacking when extracorporeal apheresis is performed. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.